ORGANISATION
„Wir streben danach, die Prostatakrebsdiagnostik schneller, kostengünstiger und weniger invasiv zu gestalten – durch die Verbindung von künstlicher Intelligenz mit Ultraschallbildgebung.“
FÜHRUNGSTEAM
Mark Bloemendaal
Chief Executive Officer
Tom Hofland
Chief Commercial Officer
Wim Zwart
Algorithm Development Lead
Armand Wemelsfelder
Product Development Lead
Anna Garrido Utrilla
Clinical Operations Manager
BEIRAT
Hessel Wijkstra
Clinical Strategic Advisor
Massimo Mischi
Scientific Strategic Advisor
Roland Zegger
Commercial Strategic Advisor
KLINISCHER BEIRAT
Prof. Dr. Hashim Ahmed
Board Member
Prof. Dr. Chris Bangma
Board Member
Prof. Dr. Harrie Beerlage
Chairman
Prof. Dr. Alberto Briganti
Board Member
Prof. Dr. Daniel Eberli
Board Member
Prof. Dr. Jurgen Fütterer
Board Member
Prof. Dr. Peter Pinto
Board Member
Prof. Dr. Hendrick van Poppel
Board Member
Prof. Dr. Georg Salomon
Board Member
Prof. Dr. Jochen Walz
Board Member